ClariMedClariMed
Diabetes Canada2018EN

Diabetes Canada Chapter 31: Neuropathy

Zusammenfassung

KEY MESSAGES: Key Messages Elevated blood glucose levels, elevated triglycerides, high body mass index, smoking and hypertension are risk factors for neuropathy. Intensive glycemic control is effective for the primary prevention or secondary intervention of neuropathy in people with type 1 diabetes. In people with type 2 diabetes, lower blood glucose levels are associated with a reduced frequency of neuropathy. Simple physical examination screening tests, such as the 10 g monofilament (on the do

Kerninformationen

esponsible for control of internal body functions and may target the heart (cardiac autonomic neuropathy), gastrointestinal tract, and genitourinary system, and can cause sexual dysfunction. Introduction Diabetes is the leading cause of neuropathy in North America (1) . Estimates of the prevalence v...
uality of life and work productivity (3,11-13) . Additionally, people with neuropathy utilize more health resources than those without (14) . Foot ulceration, which depends on the degree of foot insensitivity (15) , and amputation are important and costly sequelae of diabetic neuropathy (16) . Diabe...
th the head of the bed elevated. Specific therapies include fludrocortisone, midodrine and droxidopa (approved in the United States but not Canada), with care taken to monitor for supine hypertension (10,23,24) . Gastrointestinal neuropathies may be associated with gastroparesis, constipation, diarr...
Originaldokument ansehen

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen

Verwandte Leitlinien